AstraZeneca Pharma India's FY26 Business Responsibility and Sustainability Report shows ₹2,275.58 crore turnover. The company ceased manufacturing operations, shifting its focus to office-based business and serving Pan-India and international markets.
AstraZeneca Pharma India FY26 BRSR Highlights
Turnover: ₹2,275.58 crore
Net Worth: ₹872.79 crore
Reader Takeaway: Manufacturing cessation signals operational shift; strong board diversity and sustainability focus remain.
What just happened
AstraZeneca Pharma India has released its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report details the company's financial performance, including a turnover of ₹2,275.58 crore and a net worth of ₹872.79 crore. A significant operational update is the cessation of manufacturing activities at its facility.
Why this matters
This report provides investors with transparency on the company's strategic pivot from manufacturing to an office-based operational model. It details the impact of this change on reporting boundaries and highlights continued focus on core business activities and sustainability initiatives like 'Ambition Zero Carbon'.
The backstory
For the fiscal year 2025-26, AstraZeneca Pharma India has ceased its manufacturing operations. This marks a strategic shift in its operational structure, impacting how its business activities are reported. The company continues to serve both domestic and international markets, including Nepal.
What changes now
The company's reporting boundary has been adjusted to include shared office spaces following the cessation of manufacturing. Its business model is now centered on office-based operations, with continued focus on its science-led pharmaceutical business and serving the Pan-India and export markets.
Risks to watch
The primary watch point for investors is the cessation of manufacturing, which signifies a fundamental change in the company's asset base and operational framework. Monitoring the performance under this new model will be crucial.
Peer comparison
(No direct peer comparison data available in the filing.)
Context metrics (time-bound)
- Turnover (FY25-26): ₹2,275.58 crore
- Net Worth (FY25-26): ₹872.79 crore
- Export Sales (FY25-26): ₹117.56 crore (5.2% of turnover)
- Board Diversity: 83.33% women on the Board (5 out of 6 directors)
- Energy Consumed (FY25-26): 10,477.20 GJ
- Water Withdrawal (FY25-26): 8,203.32 kiloliters
What to track next
Investors should monitor the company's performance metrics under the new operational model and its progress on sustainability goals, particularly its 'Ambition Zero Carbon' program. The company's ability to maintain its market presence and financial health post-manufacturing cessation will be key.
The BRSR Core Indicators for the reporting period received limited assurance from KPMG Assurance and Consulting Services LLP.
Energy and water consumption metrics have been restated for year-on-year comparability.